-+ 0.00%
-+ 0.00%
-+ 0.00%

AIM IMMUNOTECH - DURIPANC OVERALL SURVIVAL ENDPOINT ANALYSIS EXPECTED TO BEGIN JUNE 2027

Reuters·08/03/2026 12:34:08

Please log in to view news